RE: Will deal be withPzifer ?9 Jan 2018 14:56
High Goldust 88 With the 92,000 buy today, the most recognized publication in the industries positive review as well as the great progress towards USD Phase III approval - The fact that Pfizer are contributing to medical articles publicly and TV this morning will mean that this will probably hit 100p plus again soon, once it takes off it will likely remain at much much higher levels. I'm sure GSK and the other companies must be thinking do we take this out now at say 100p to 150p or leave it when it might cost us 300p in an aggressive takeover which I feel will happen immediately and if USDA Phase III approvals are granted. Sort of share that if it captures the USD 6 billion annualised revenue market probably worth 700 to 900p / share without a stretch within 24 / 36 months.